Amcor (ASX: AMC) Struggles with Integration Risks Despite Global Scale: Sell Rating on AMC

Key Takeaways: Amcor’s recent Berry Global acquisition, completed in April 2025, brings scale and $650 million in expected synergies but has increased integration costs and operational complexity. In Q4 FY25, the company posted a GAAP net loss of $39 million and gross margins fell to 18.9%, while full-year net sales rose 11% to USD 15.0 billion and adjusted EPS reached $0.71. Free cash flow came in at USD 926 million, but high leverage, with total debt of USD 14.1 billion, a debt-to-equity ratio of 1.28, and net debt at 123.5% of equity, limits flexibility. While a forward P/E of around 10x FY26 earnings looks attractive, near-term upside is constrained if Berry integration and margin recovery face delays. We therefore issue a SELL rating with a target price of A$12.36. --- Amcor CDI (ASX:AMC) is one of the world’s largest packaging companies, spanning over 40 countries with more than 400 locations. Its core business is Flexible Packaging, which drives about 90% of earnings, while Rigid Packaging remains centred on beverages in the Americas. This global reach and diversified product offering should be strengths, but the sheer complexity of its operations has been amplified by the recent acquisition of Berry Global. Berry Global Acquisition Brings Scale, but Short-Term Pain The Berry Global deal, completed in April 2025, is expected to deliver $650 million in synergies, making it one of the most significant acquisitions in Amcor’s history. However, integration costs are already weighing heavily. In Q4 FY25, Amcor posted a GAAP net loss of $39 million, while gross margins compressed to 18.9%. For the full year, net sales rose 11% to $15.0 billion (ex-currency), but adjusted EPS only edged up to $0.71, reflecting modest earnings power against mounting expenses. Free cash flow came in at $926 million, within guidance but tight when measured against dividends and debt service.

Ambitious Guidance for FY26 Looks Difficult to Achieve Management has guided for 12–17% adjusted EPS growth and $1.8–1.9 billion in free cash flow for FY26. On paper, this would mark a sharp rebound in profitability and cash generation. But given the challenges of integrating Berry, ongoing cost inflation, and the execution risks inherent in capturing synergies, we view these targets as optimistic. If synergy benefits are delayed or diluted, earnings forecasts may face downward revisions. Leverage and Balance Sheet Constraints Limit Flexibility Amcor’s balance sheet remains stretched, with several key figures underscoring the risks: - Total debt: $14.1 billion – a heavy burden that constrains capital flexibility. - Debt-to-equity ratio: 1.28 – reflecting a still-elevated level of leverage. - Net debt to equity: 123.5% – down to a five-year low, but leverage remains high. - Interest coverage ratio: 3.8x – suggests obligations can be serviced, though limited room for shocks. Taken together, these figures highlight a company that can meet its debt obligations but has little flexibility to accelerate deleveraging, pursue further acquisitions, or invest aggressively without stretching its balance sheet. Valuation Screens Cheap, but We See a Value Trap At first glance, Amcor’s forward P/E of around 10x FY26 earnings looks attractive compared to historical levels. But we caution that the market is already pricing in successful execution of the Berry integration. With free cash flow only just starting to improve, and margins under strain, the stock could remain stuck near its 52-week lows. Technical resistance is likely to cap any rebound until Amcor proves it can deliver on its ambitious guidance. Amcor remains a global packaging powerhouse with a strong commitment to sustainability, including its goal for 100% recyclable, reusable, or compostable packaging by 2025. But right now, the integration challenges, high leverage, and earnings volatility outweigh the positives. We believe the market is overestimating near-term execution, leaving limited upside from current levels. We therefore issue a SELL rating with a target price of A$12.36 per share, reflecting our cautious stance over the next 12–18 months.